Why pharma needs honest patient dialogue

Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience.

What are your key ambitions in your current role?

Without question, diversity and inclusion is something that I’m very passionate about – not just from an employee perspective but making sure that we truly represent the society we serve, and that we conduct clinical trials that are well-developed and are truly representative.

Starting with our leadership team, we’ve improved the gender balance over the last year by 50%. I believe diversity is a business imperative. When we have diversity of thought around the table, diversity of ideas and diversity of backgrounds, it benefits our company and the patients we serve in the long run.

• Read the full article in pharmaphorum's Deep Dive digital magazine